The global autoimmune disease diagnosis market is expected to reach USD 4.73 billion by 2022 from USD 3.09 billion in 2017, at a CAGR of 8.9%

Monday, February 5, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

The autoimmune disease diagnosis market projected to grow at a CAGR of 8.9% during the forecast period.

LONDON, Fev. 5, 2018 /PRNewswire/ -- Download the full report: https://www.reportbuyer.com/product/5305542 The global autoimmune disease diagnosis

market is expected to reach USD 4.73 billion by 2022 from USD 3.09 billion in 2017, at a CAGR of 8.9%. Factors driving the growth of this market include the rising incidence of autoimmune diseases, growing healthcare expenditure, increasing access to medical insurance in the US, and technological advancements in diagnosis devices. On the other hand, the high cost of analyzers and other instruments is expected to challenge market growth to a certain extent The consumables and assay kits segment is anticipated to grow at the fastest growth rate during the forecast period. The autoimmune disease diagnosis market by product and service is categorized into consumables & assay kits, instruments, and services. The consumables and assay kits segment is expected to register the highest CAGR during the forecast period. The growing adoption of consumables and assay kits for the diagnosis of autoimmune diseases is the key factors driving the growth of this market The routine laboratory tests segment is anticipated to grow at the fastest growth rate during the forecast period. The autoimmune disease diagnosis market by test type is categorized into routine laboratory tests, inflammatory markers, autoantibodies and immunologic tests, and other tests. The routine laboratory test segment is expected to register the highest CAGR during the forecast period. The growth of this segment is mainly driven by the increasing adoption of routine laboratory tests for a variety of diseases The rheumatoid arthritis segment is anticipated to grow at the fastest growth rate during the forecast period. The autoimmune disease diagnosis market by disease is categorized into systemic lupus erythematosus, rheumatoid arthritis, Sjögren's syndrome, thyroiditis, scleroderma, and other diseases. The rheumatoid arthritis segment is expected to register the highest CAGR during the forecast period. The growing use of instruments and consumables for the diagnosis and treatment of rheumatoid arthritis, increasing awareness regarding autoimmune diseases, and the development of novel products are the key factors driving the growth of this market The clinical laboratories segment is estimated to grow at a rapid rate during the forecast period By end user, the autoimmune disease diagnosis market is segmented into clinical laboratories, hospitals, and other end users. The clinical laboratories segment is expected to grow at highest CAGR during the forecast period. Factors such as the rising number of patients suffering from autoimmune diseases and improving healthcare infrastructure are driving the growth of this segment Asia is estimated to grow at the highest CAGR during the forecast period Geographically, the autoimmune disease diagnosis market is dominated by North America, followed by Europe in 2017, however, Asia is estimated to grow at the fastest rate during the forecast period. Growth in this region can be attributed to developing healthcare infrastructure, rising burden of autoimmune diseases, and increasing initiatives to promote the use of novel technologies for autoimmune disease diagnosis in Asian countries. The primary interviews conducted for this report can be categorized as follows: • By Company Type - Tier 1 – 70% and Tier 2 – 30% • By Designation – C level – 62%, Director level – 21%, Others – 17% • By Region – North America – 50%, Asia– 30%, Europe – 20% The key players in the autoimmune disease diagnosis market include Thermo Fisher Scientific. (US), Danaher (US), HYCOR Biomedical (US), Siemens (Germany), Bio-Rad (US), Inova Diagnostics (US), Trinity Biotech (Ireland), GRIFOLS. (Spain), and Abbott (US). Research Coverage: The report analyses the autoimmune disease diagnosis market by product, test type, disease, end user, and region. Apart from a comprehensive geographic product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles include the product portfolios, developments, and strategies adopted by prominent market players to maintain and increase their shares in the market. Market research data, current market size, and forecast of future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output to remain successful in the market. Key benefits of buying the Report: This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies for strengthening their market shares. The report provides insights on the following pointers: • Market Penetration: Comprehensive information on the product portfolios of the top players in the autoimmune disease diagnosis market • Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the autoimmune disease diagnosis market • Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the autoimmune disease diagnosis market • Market Development: Comprehensive information about emerging markets. This report analyzes the market for various autoimmune disease diagnosis and services across geographies • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the autoimmune disease diagnosis market.Download the full report: https://www.reportbuyer.com/product/5305542 About Reportbuyer Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: sarah@reportbuyer.com  Tel: +1 (718) 213 4904 Website: www.reportbuyer.com

Cision View original content:http://www.prnewswire.com/news-releases/the-global-autoimmune-disease-diagnosis-market-is-expected-to-reach-usd-473-billion-by-2022-from-usd-309-billion-in-2017-at-a-cagr-of-89-300593432.html

SOURCE ReportBuyer

Advertisement


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store